Sort
40,608 grants matching “prostate cancer”
Investigation of Membrane-Bound Cytochromes-P450-b5 Interactions
$420,762Ayyalusamy Ramamoorthy · University Of Michigan At Ann Arbor · R01 · FY2017 · GM
A Novel Device to Allow Zoom-In Imaging for PET Scanners
$420,742Washington University · R33 · FY2005 · CA
QuBBD: Collaborative Research: Quantifying Morphologic Phenotypes in Prostate Cancer - Developing Topological Descriptors for Machine Learning Algorithms
$420,706Brittany T Fasy · Montana State University · · FY2017 · MPS
Hormone signaling and translation control in advanced prostate cancer
$420,691Andrew Caleb Hsieh · Fred Hutchinson Cancer Research Center · R37 · FY2019 · CA
Hormone signaling and translation control in advanced prostate cancer
$420,691Andrew Caleb Hsieh · Fred Hutchinson Cancer Research Center · R37 · FY2020 · CA
Hormone signaling and translation control in advanced prostate cancer
$420,691Andrew Caleb Hsieh · Fred Hutchinson Cancer Research Center · R37 · FY2021 · CA
HCA (HIGH CONTENT ANALYSIS) OF THE ANDROGEN RECEPTOR IN METASTATIC PROSTATE CANCER
$420,665Baylor College Of Medicine · · FY2010 · Department of Defense
Design of novel c-Met inhibitors inspired by olive phenolics
$420,540Khalid A El Sayed · University Of Louisiana At Monroe · R15 · FY2013 · CA
AKT-independent Pathways of Phosphoinositide 3-kinase dependent transformation
$420,525Charles L Sawyers · Beth Israel Deaconess Medical Center · P01 · FY2011 · CA
Project 4: The BRCA Network in Medulloblastoma Responses to Replication Stress
$420,491Zhiyuan Shen · Rutgers Biomedical And Health Sciences · P01 · FY2023 · CA
Leveraging Tumor Suppressor Inactivation for Osteosarcoma Therapy
$420,442Bang H Hoang · Albert Einstein College Of Medicine · R01 · FY2021 · CA
SYNERGISTIC MULTIMODALITY ANTIBODY THERAPY
$420,273University Of California Davis · P01 · FY2002 · CA
A non-canonical role for EZH2 in rRNA methtlation
$420,147Qi Cao · Northwestern University At Chicago · R01 · FY2023 · CA
A non-canonical role for EZH2 in rRNA methtlation
$420,147Qi Cao · Northwestern University At Chicago · R01 · FY2022 · CA
Targeting Ferroptosis in Lethal RB1 Deficient Prostate Cancer
$420,140Ming Hui Chen · Duke University · R01 · FY2022 · CA
Targeting Ferroptosis in Lethal RB1 Deficient Prostate Cancer
$420,140Ming Hui Chen · Duke University · R01 · FY2025 · CA
Development of Protein Biomarkers in Post-DRE Urine for use in Liquid Biopsy of Prostate Cancer
$420,061Oliver John Semmes · Eastern Virginia Medical School · U01 · FY2019 · CA
Discovery and verification of novel biomarkers of colorectal cancer recurrence
$420,049Christopher I Li · Fred Hutchinson Cancer Research Center · R01 · FY2020 · CA
CDK inhibitors in tumor progression
$420,049Andrew Koff · Sloan-Kettering Inst Can Research · R01 · FY2010 · CA
Development of a Novel TGF-beta Antagonist for Treating Hepatic Fibrosis
$420,003Jung S. Huang · Saint Louis University · RC1 · FY2010 · AA
Materials World Network (MWN): Chemistry of Porous Silicon Nanoparticles for Photodynamic Therapy
$420,000Michael J Sailor · University Of California-San Diego · · FY2012 · MPS
REPRODUCTIVE AND DEVELOPMENTAL TOXICITY OF DIOXIN
$419,937Richard E Peterson · University Of Wisconsin-Madison · R37 · FY2007 · ES
Genetic and Molecular Basis of Rapamycin Sensitivity
$419,914Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2005 · CA
Probe Optimization for Prostate Cancer Detection
$419,835Clifford Berkman · Washington State University · R01 · FY2013 · CA
SBIR Phase II: High throughput screening for splice variant cDNAs
$419,813Jean-Michel A Lelias · Genofi, Llc · R44 · FY2008 · HG